Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice. [electronic resource]
Producer: 20120305Description: 104-11 p. digitalISSN:- 1872-8057
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme 2
- Animals
- Apoptosis -- drug effects
- Diabetes Mellitus, Experimental
- Diabetic Nephropathies -- prevention & control
- Enzyme Activation
- Gene Expression
- Imidazoles -- pharmacology
- Intracellular Signaling Peptides and Proteins -- metabolism
- Kidney -- drug effects
- MAP Kinase Signaling System -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- Oxidative Stress
- Peptidyl-Dipeptidase A -- genetics
- Phosphorylation
- Protein Serine-Threonine Kinases -- metabolism
- Proto-Oncogene Mas
- Proto-Oncogene Proteins -- genetics
- Receptor, Angiotensin, Type 1 -- metabolism
- Receptors, G-Protein-Coupled -- genetics
- Tetrazoles -- pharmacology
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.